GB9513342D0 - Complexes - Google Patents

Complexes

Info

Publication number
GB9513342D0
GB9513342D0 GBGB9513342.7A GB9513342A GB9513342D0 GB 9513342 D0 GB9513342 D0 GB 9513342D0 GB 9513342 A GB9513342 A GB 9513342A GB 9513342 D0 GB9513342 D0 GB 9513342D0
Authority
GB
United Kingdom
Prior art keywords
complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9513342.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB9513342.7A priority Critical patent/GB9513342D0/en
Publication of GB9513342D0 publication Critical patent/GB9513342D0/en
Priority to AU62373/96A priority patent/AU6237396A/en
Priority to JP9504018A priority patent/JPH11509089A/ja
Priority to CA002224940A priority patent/CA2224940A1/en
Priority to EP96921006A priority patent/EP0835319A1/en
Priority to PCT/GB1996/001560 priority patent/WO1997002354A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB9513342.7A 1995-06-30 1995-06-30 Complexes Pending GB9513342D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9513342.7A GB9513342D0 (en) 1995-06-30 1995-06-30 Complexes
AU62373/96A AU6237396A (en) 1995-06-30 1996-06-28 Interaction of p53 with transcription factor dp-1
JP9504018A JPH11509089A (ja) 1995-06-30 1996-06-28 ｐ５３と転写因子ＤＰ−１との相互作用
CA002224940A CA2224940A1 (en) 1995-06-30 1996-06-28 Interaction of p53 with transcription factor dp-1
EP96921006A EP0835319A1 (en) 1995-06-30 1996-06-28 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1
PCT/GB1996/001560 WO1997002354A1 (en) 1995-06-30 1996-06-28 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9513342.7A GB9513342D0 (en) 1995-06-30 1995-06-30 Complexes

Publications (1)

Publication Number Publication Date
GB9513342D0 true GB9513342D0 (en) 1995-09-06

Family

ID=10776918

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9513342.7A Pending GB9513342D0 (en) 1995-06-30 1995-06-30 Complexes

Country Status (6)

Country Link
EP (1) EP0835319A1 (ja)
JP (1) JPH11509089A (ja)
AU (1) AU6237396A (ja)
CA (1) CA2224940A1 (ja)
GB (1) GB9513342D0 (ja)
WO (1) WO1997002354A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159691A (en) * 1996-05-15 2000-12-12 Prolifix Limited Assay for a putative regulator of cell cycle progression
GB9610195D0 (en) * 1996-05-15 1996-07-24 Medical Res Council Assay
US6387649B1 (en) 1996-09-30 2002-05-14 Prolifix Limited Assay for a regulator of cell cycle progression
GB9724828D0 (en) * 1997-11-21 1998-01-21 Univ Glasgow Gene
FR2775003A1 (fr) * 1998-02-19 1999-08-20 Transgene Sa Methode de criblage de composes capables d'inhiber la fixation entre le facteur de transcription stat1 et le facteur de transcription usf1
EP1163341A2 (en) * 1999-03-19 2001-12-19 CropDesign N.V. Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
CN101300323B (zh) 2005-11-07 2012-02-08 Lg化学株式会社 用于液晶定向的共聚物、包含用于液晶定向的共聚物的液晶定向层，以及包括液晶定向层的液晶显示器

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0654092B1 (en) * 1992-06-26 2003-09-10 The Trustees Of Princeton University Method for detecting pre-cancerous or cancerous cells using p90 and p53 antibodies or probes

Also Published As

Publication number Publication date
JPH11509089A (ja) 1999-08-17
EP0835319A1 (en) 1998-04-15
AU6237396A (en) 1997-02-05
WO1997002354A1 (en) 1997-01-23
CA2224940A1 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
PL322583A1 (en) Triple radiophramaceutic complexes
DE59607964D1 (en) Oxymethoxy-3-aryl-pyron-derivate
DE59607241D1 (en) Endotracheal-tubus
DE59608164D1 (en) Cyclohexenonoximether-metallsalze
GB9511396D0 (en) Chemical complexes
DE59605001D1 (en) Luftreinigungsgerät
DE59602888D1 (en) Breitstreckaggregat
GB9513342D0 (en) Complexes
DE59602283D1 (en) Inchbremseinrichtung
HUP9603330A2 (en) Energycable
GB9518539D0 (en) Complex
DE59505396D1 (en) Handhobelmaschine
AP9600802A0 (en) Libricant
GB9515308D0 (en) Complex
DE59604506D1 (en) Rückkühlsystem
DE59600830D1 (en) Breitstrahldüse
DE59604913D1 (en) Carbonylverbindungen
GB9502637D0 (en) Reduction
IL113924A0 (en) Mechanotherapy complex
ZA969476B (en) Complex
AU1105P (en) DALESE Metrosideros excelsus
DE59609059D1 (en) Conventional-direct-glazing
GB9514902D0 (en) Metal complexes
EP0822821A4 (en) COMPLEXING URUSHIOLES
ZA962812B (en) Reduction